Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix A Meeting Agenda Evidence-Based Medicine and the Changing Nature of Health Care The National Academy of Sciences Building 2100 C Street, N.W. Washington, D.C. Monday, October 8 9:20 a.m. Introduction of the Program Mark B. McClellan, M.D., Ph.D., Senior Fellow and Director, Engelberg Center for Health Care Reform, Leonard D. Schaeffer Chair in Health Policy Studies, Economic Studies, The Brookings Institution Elizabeth G. Nabel, M.D., Director, National Heart, Lung, and Blood Institute, National Institutes of Health 9:30 a.m. hat Forces Are Driving the Need for Better Medical W Evidence? Chair: Denis A. Cortese, M.D., President and Chief Executive Officer, Mayo Clinic R elationship Between Health Care and the Evidence Base: Current Profile Elliott S. Fisher, M.D., M.P.H., Professor of Medicine and Community and Family Medicine, Center for the Evaluative Clinical Sciences, Dartmouth Medical School H ow the Pace of New Health Product Introduction Affects the Need for Evidence Molly J. Coye, M.D., M.P.H., Founder and Chief Executive Officer, Health Technology Center 173
174 EVIDENCE-BASED MEDICINE H ow the Pace of New Insights into Genetic Variation Affects the Need for Evidence David M. Altshuler, Ph.D., M.D., Director of Medical and Population Genetics, Broad Institute I mpact of the Evidence Shortfall on Health Care Costs, Public Budgets, and the Economy Peter R. Orszag, Ph.D., Director, Congressional Budget Office 10:30 a.m. Questions and Discussion 10:50 a.m. Break 11:10 a.m. ow Can Patients and Providers Contend with the H Changes? Chair: Michael M. E. Johns, M.D., Chancellor, Emory University P ractical Front-Line Challenges and the Future of Expert- Based Care William W. Stead, M.D., McKesson Foundation Professor of Medicine and Biomedical Informatics, and Associate Vice Chancellor for Strategy and Transformation, Vanderbilt University T he Patient-Physician Partnership in Fostering an Evidence- Driven Environment Marc Boutin, Esq., Executive Vice President, National Health Council I nformation Technology Tools That Support Best Practices by Healthcare Providers Robert Hayward, M.D., M.P.H., F.R.C.P.C., Associate Professor, Departments of Medicine and Public Health Sciences, and Director, Centre for Health Evidence, University of Alberta C onsumer-Accessible, Web-Based Health Information to Empower Patients Peter M. Neupert, M.B.A., Corporate Vice President, Health Solutions Group, Microsoft Corporation 12:10 p.m. Questions and Discussion 12:30 p.m. Lunch Break
APPENDIX A 175 2:00 p.m. hatâs Needed to Transform the Speed and Reliability W of New Evidence? Chair: John W. Rowe, M.D., Professor, Department of Health Policy and Management, Columbia University Mailman School of Public Health E lectronic Health Records and the Prospect of Real-Time Evidence Development George C. Halvorson, Chairman and Chief Executive Officer, Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals R esearch Methods to Speed the Development of Better Evidence Eric D. Peterson, M.D., M.P.H., Professor of Medicine, Duke Clinical Research Institute B iopharmaceutical and Medical Device Development: Tailored Therapies Meet Evidence-Based Medicine Steven M. Paul, M.D., Executive Vice President, Science and Technology, and President, Lilly Research Laboratories, Eli Lilly and Company 2:45 p.m. Questions and Discussion 3:00 p.m. ow Can Policy Changes Improve the Value We Get from H Health Care? Chair: John K. Iglehart, Founding Editor, Health Affairs, and National Correspondent, New England Journal of Medicine What Is Value in Health Care? Michael E. Porter, Ph.D., Bishop William Lawrence University Professor, Harvard Business School R egulatory and Financing Reforms Necessary for Effective Health Care Donna E. Shalala, Ph.D., President, University of Miami 3:30 p.m. Questions and Discussion 4:00 p.m. Closing Remarks Mark B. McClellan, M.D., Ph.D. Elizabeth G. Nabel, M.D.
